diclofenac has been researched along with Sclerosis, Systemic in 4 studies
Diclofenac: A non-steroidal anti-inflammatory agent (NSAID) with antipyretic and analgesic actions. It is primarily available as the sodium salt.
diclofenac : A monocarboxylic acid consisting of phenylacetic acid having a (2,6-dichlorophenyl)amino group at the 2-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We describe a patient with scleroderma who developed immune thrombocytopenia secondary to diclofenac on 2 occasions." | 7.68 | Diclofenac induced immune thrombocytopenia. ( Epstein, M; Stein, H; Vickars, L, 1990) |
| "We describe a patient with scleroderma who developed immune thrombocytopenia secondary to diclofenac on 2 occasions." | 3.68 | Diclofenac induced immune thrombocytopenia. ( Epstein, M; Stein, H; Vickars, L, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (25.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, BE | 1 |
| Jiang, X | 1 |
| Zhang, Q | 1 |
| Liang, Q | 1 |
| Qiu, ZL | 1 |
| Sun, XB | 1 |
| Yang, JJ | 1 |
| Chen, S | 1 |
| Yi, C | 1 |
| Chai, X | 1 |
| Liu, M | 1 |
| Yu, LF | 1 |
| Lu, W | 1 |
| Zhang, HK | 1 |
| Richard, V | 1 |
| Solans, V | 1 |
| Favre, J | 1 |
| Henry, JP | 1 |
| Lallemand, F | 1 |
| Thuillez, C | 1 |
| Marie, I | 1 |
| Epstein, M | 1 |
| Vickars, L | 1 |
| Stein, H | 1 |
| Kagan, A | 1 |
| Nissim, F | 1 |
| Green, L | 1 |
| Bar-Khayim, Y | 1 |
1 review available for diclofenac and Sclerosis, Systemic
| Article | Year |
|---|---|
Scleroderma renal crisis without hypertension.
Topics: Acute Kidney Injury; Diclofenac; Female; Humans; Middle Aged; Scleroderma, Systemic | 1989 |
3 other studies available for diclofenac and Sclerosis, Systemic
| Article | Year |
|---|---|
From a Designer Drug to the Discovery of Selective Cannabinoid Type 2 Receptor Agonists with Favorable Pharmacokinetic Profiles for the Treatment of Systemic Sclerosis.
Topics: Designer Drugs; Drug Discovery; Humans; Receptor, Cannabinoid, CB2; Scleroderma, Systemic; Structure | 2021 |
Role of endogenous endothelin in endothelial dysfunction in murine model of systemic sclerosis: tight skin mice 1.
Topics: Acetylcholine; Animals; Bosentan; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Dos | 2008 |
Diclofenac induced immune thrombocytopenia.
Topics: Diclofenac; Humans; Immune System Diseases; Male; Middle Aged; Platelet Count; Prednisone; Scleroder | 1990 |